Sangamo Therapeutics (SGMOQ) Interest Coverage Ratio (2011 - 2025)

Sangamo Therapeutics' (SGMOQ) quarterly Interest Coverage Ratio came in at 0.09 in Q4 2025, down 28.71% year-on-year from 0.13 in Q4 2024, and down 28.71% quarter-over-quarter from 0.07 in Q4 2024.

Sangamo Therapeutics (SGMOQ) Interest Coverage Ratio (2011 - 2025) Analysis & Trends

Sangamo Therapeutics' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 0.09 for Q4 2025.

  • On a quarterly basis, Interest Coverage Ratio fell 28.71% year-over-year to 0.09 in Q4 2025; TTM through Dec 2025 was 0.29, a 2.11% decrease from a year earlier, with the FY2025 full-year figure at 0.29, down 2.11% from the prior year.
  • Interest Coverage Ratio fell to 0.09 in Q4 2025 per SGMOQ's latest filing, from 0.07 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 46.12 in Q1 2023 and bottomed at 2086.43 in Q3 2023.
  • The 5-year median for Interest Coverage Ratio is 25.35 (2021), against an average of 187.25.
  • Biggest YoY gain for Interest Coverage Ratio was 240.22% in 2023; the steepest drop was 5266.78% in 2023.
  • Year by year, Interest Coverage Ratio stood at 23.47 in 2021, then slumped by 733.96% to 195.73 in 2022, then jumped by 99.91% to 0.18 in 2023, then surged by 59.96% to 0.07 in 2024, then retreated by 28.71% to 0.09 in 2025.
  • Per Business Quant, the three latest SGMOQ Interest Coverage Ratio figures stand at 0.09 (Q4 2025), 0.07 (Q4 2024), and 0.18 (Q4 2023).

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.09
Dec 31, 2024 -0.07
Dec 31, 2023 -0.18
Sep 30, 2023 -2,086.43
Jun 30, 2023 -227.15
Mar 31, 2023 46.12
Dec 31, 2022 -195.73
Sep 30, 2022 -38.88
Jun 30, 2022 -29.77
Mar 31, 2022 -32.89
Dec 31, 2021 -23.47
Sep 30, 2021 -0.97
Jun 30, 2021 -4.71
Mar 31, 2021 -27.24
Dec 31, 2020 -25.55
Sep 30, 2020 -0.07
Jun 30, 2020 -0.69
Mar 31, 2020 -27.83
Sep 30, 2019 -7.63
Jun 30, 2019 -70.36